MOTS-c dosage for weight loss is not FDA-approved, but research protocols often use 5–10 mg weekly. Learn what studies show, plus safety and alternatives.
There is no established MOTS-c dosage for weight loss in humans. MOTS-c is an experimental mitochondrial-derived peptide that is not FDA-approved, and no published clinical trial has identified a dose that reliably produces weight loss in people. Protocols discussed online usually fall between 5 mg and 10 mg per week, often split into smaller daily injections, but those numbers come from early studies of blood sugar and insulin markers — not from weight-loss trials.
What MOTS-c Is and Why It Gets Mentioned for Weight Loss
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. Unlike most peptides, it originates inside the mitochondria, where it helps regulate how cells handle glucose and fatty acids.
Interest in mots-c for weight loss grew mainly from mouse research. In several rodent studies, obese mice given MOTS-c lost fat, became more insulin sensitive, and burned more energy even without extra exercise.
Human data is much thinner. Small studies have examined how natural MOTS-c levels relate to insulin resistance, and a related analog called CB4211 has gone through early human testing for fatty liver disease. None of those studies were designed to measure pounds lost.
Reported MOTS-c Dosage Protocols
Because no regulatory body has approved MOTS-c for human use, there is no official dose. What follows is a summary of what appears in published research and in user reports — not a recommendation.
Dose ranges people cite
- 1 mg to 5 mg per week in lighter protocols, sometimes divided into 0.5 mg–1 mg injections several times per week.
- 5 mg to 10 mg per week is the most commonly repeated range, often split into daily or every-other-day shots.
- 10 mg to 15 mg per week shows up in higher-dose anecdotes and in early metabolic studies that used single large subcutaneous doses to test glucose handling.
Frequency and injection site
MOTS-c has a short half-life in circulation, so some protocols use daily or every-other-day dosing instead of one weekly injection. Commonly reported sites are the abdomen or thigh, rotating the spot to limit irritation.
Most of what circulates online about a mots c dosage for weight loss plan comes from forums and vendor blogs rather than controlled trials. That means the ranges above are educated guesses dressed up as protocols.
What the Human Evidence Shows — and Doesn't
MOTS-c has real biological activity. Animal studies show it activates AMPK, the same energy-sensing pathway triggered by exercise, and improves glucose uptake in muscle tissue.
The gap is human weight-loss evidence. As of today:
- No trial has used body fat or body weight as a primary endpoint for MOTS-c.
- Human studies have been small, short, and focused on metabolic markers rather than fat loss.
- People who report visible results are usually also dieting, training, or using GLP-1 medications at the same time.
No MOTS-c dose has been proven to cause weight loss in humans. Anyone claiming a specific number is extrapolating from rodent data.
MOTS-c vs. Other Weight-Loss Options
MOTS-c is frequently grouped with peptides and prescription drugs it does not resemble. The evidence base behind each option is very different.
| Option | Typical reported dose | Route | Regulatory status |
|---|---|---|---|
| MOTS-c | 5–10 mg per week, often split | Subcutaneous | Not FDA-approved; sold as a research chemical |
| Tirzepatide (Zepbound) | 2.5 mg weekly, titrated up to 15 mg | Subcutaneous | FDA-approved for weight management |
| Semaglutide (Wegovy) | 0.25 mg weekly, titrated up to 2.4 mg | Subcutaneous | FDA-approved for weight management |
| 5-amino-1MQ | Varies widely; no standard dose | Subcutaneous or oral | Not FDA-approved; sold as a research chemical |
| CJC-1295 with DAC | 1–2 mg weekly in user reports | Subcutaneous | Not FDA-approved; sold as a research chemical |
Prescription drugs come with titration schedules built from trials involving thousands of participants. If you are weighing medical options, a tirzepatide dosage chart for weight loss and a clinician's guidance will be far more useful than a peptide forum.
It also helps to understand how dose changes work in approved therapy. Increasing ozempic dosage for weight loss, for example, follows a stepwise schedule monitored by a prescriber — the opposite of the trial-and-error approach common in peptide circles.
Other compounds get compared to MOTS-c for unrelated reasons, and people researching metabolic peptides often ask about 5-amino-1mq dosage subcutaneous for weight loss in the same breath. Growth-hormone secretagogues such as CJC-1295 are a separate category with different biology altogether.
Safety, Sourcing, and Legal Status
MOTS-c is not approved by the FDA for human use in the United States. It is sold as a "research chemical," which means the product is not reviewed for purity, sterility, or correct dosing.
Reported side effects are mostly mild and include injection-site redness, swelling, and brief fatigue. Because long-term human data is essentially absent, the risks of repeated use are unknown.
Anyone who is pregnant, breastfeeding, managing a medical condition, or taking prescription medication should speak with a healthcare professional before injecting any unapproved peptide. Self-dosing with an unverified compound is an expensive way to gamble with your health.
Questions Worth Asking Before You Start
- Is there a diagnosis, such as prediabetes or obesity, that a clinician could treat with an approved therapy?
- Does the certificate of analysis for the vial cover sterility and endotoxin testing, not just peptide identity?
- Is the plan measurable, with baseline labs and a defined stop date?
The honest summary: MOTS-c is fascinating science, but it is not a proven weight-loss drug. The correct dose is unknown because it has never been established in humans.
Frequently Asked Questions
What is the typical MOTS-c dosage for weight loss?
There is no standard or FDA-recognized dose. Community protocols most often cite 5 mg to 10 mg per week, sometimes split into 0.5 mg–1 mg injections given daily or every other day. No human trial has confirmed that any of these amounts produces weight loss.
Is MOTS-c legal and safe to buy in the United States?
MOTS-c is not FDA-approved for human use and is legally sold only as a research chemical, so purity and sterility are not guaranteed. Reported side effects are usually mild, such as injection-site irritation, but long-term safety in humans is unknown.
How much weight can you lose with MOTS-c?
No clinical study has measured weight loss from MOTS-c in people, so there is no reliable figure. Rodent studies show fat loss and better insulin sensitivity, but participants who report results online are typically also dieting, exercising, or using GLP-1 medications.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.